𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimizing treatment for elderly patients with acute promyelocytic leukemia: is it time to replace chemotherapy with all-trans retinoic acid and arsenic trioxide?

✍ Scribed by Tsimberidou, Apostolia-Maria; Kantarjian, Hagop; Keating, Michael J.; Estey, Elihu

Book ID
121268127
Publisher
Informa plc
Year
2006
Tongue
English
Weight
421 KB
Volume
47
Category
Article
ISSN
1042-8194

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Acute promyelocytic leukemia: All-trans
Acute promyelocytic leukemia: All-trans retinoic acid (ATRA) along with chemotherapy is superior to ATRA alone
✍ Advani, Suresh H.; Nair, Reena; Bapna, Ajay; Gladstone, Betty; Kadam, Pratibha; πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 2 views

This study was conducted to compare the results of treatment of acute promyelocytic leukemia (APL) with all-trans retinoic acid alone (ATRA) or a combination therapy of ATRA followed by chemotherapy. Forty-three patients treated between February 1992 and February 1996 were included in this study. Ei

An efficient therapeutic approach to pat
An efficient therapeutic approach to patients with acute promyelocytic leukemia using a combination of arsenic trioxide with low-dose all-trans retinoic acid
✍ Guanjun Wang; Wei Li; Jiuwei Cui; Sujun Gao; Cheng Yao; Zhenyu Jiang; Yanqiu Son πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 79 KB πŸ‘ 1 views

## Abstract The use of arsenic trioxide (As~2~O~3~, ATO) combined with all‐trans retinoic acid (ATRA) has recently been reported to induce remission in patients with acute promyelocytic leukemia (APL). However, its efficiency remains inconclusive mainly due to the small number of the available case